Blue Jet Healthcare Limited

As of June 30, 2026, Blue Jet Healthcare Limited carries a market capitalization of 91.10B, placing it among publicly traded companies globally. Its enterprise value stands at 91.10B, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

Blue Jet Healthcare Limited's next confirmed earnings release is scheduled for November 5, 2026.

As of June 30, 2026, Blue Jet Healthcare Limited has 173.47M shares outstanding.

As of June 30, 2026, Blue Jet Healthcare Limited trades at a trailing price-to-earnings ratio of 33.24.

As of June 30, 2026, Blue Jet Healthcare Limited trades at an EV/EBITDA multiple of 27.02 - the valuation measure that neutralizes differences in capital structure, tax rates, and depreciation policy, making it the standard yardstick for comparing companies across an industry. The EV/Sales ratio of 8.48 reflects the premium investors pay for the company's revenue stream, a useful check when earnings are depressed or negative. Its EV/EBIT multiple of 29.16 values the business against core operating earnings after depreciation, a stricter test than EV/EBITDA for capital-intensive businesses. These enterprise value multiples are built on an enterprise value of 91.10B versus a market cap of 91.10B, with the gap driven by net debt and cash on the balance sheet.

These figures are as of June 30, 2026.

These figures cover the twelve months ended June 30, 2026. The company generates approximately 19.92M in revenue per employee across its workforce of 539.50, a quick read on workforce productivity versus industry peers.

Over the twelve months ended June 30, 2026, Blue Jet Healthcare Limited recorded 957.88M in income tax expense. That works out to an effective tax rate of 25.91, which can sit above or below the statutory corporate tax rate depending on foreign earnings mix, tax credits, and one-off items. Taxes are levied on pretax income of 3.70B, leaving 2.74B in net income after tax - the gap is what shifts in the tax rate do to reported earnings and EPS.

As of the close on October 23, 2026, Blue Jet Healthcare Limited's stock has declined approximately 26.95% over the past 52 weeks. The 50-day moving average sits at 559.96, while the 200-day moving average is 488.44.

Over the twelve months ended June 30, 2026, Blue Jet Healthcare Limited generated 10.75B in revenue and converted that into 2.74B in net income, yielding earnings per share of 15.80. EBITDA reached 3.37B, while operating income came in at 3.12B.

Over the twelve months ended June 30, 2026, Blue Jet Healthcare Limited posted a gross margin of 52.09, reflecting its pricing power and cost economics. The operating margin of 29.06 and net profit margin of 25.48 provide insight into operational efficiency.